Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping Dong

Showing results (1011-1020 of 1,056) with videos related to

Pageof 106
Sort By:
Chinese Medical Journal|August 31, 2012
An uncontrolled open-label, multicenter study to monitor the antiviral activity and safety of inhaled zanamivir (as Rotadisk via Diskhaler device) among Chinese adolescents and adults with influenza-like illnessBin Cao, Da-Yan Wang, Xiao-Min Yu, et al.
Cell|April 21, 2010
TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formationXiping Cheng, Jie Jin, Lily Hu, et al.
Acta Pharmacologica Sinica|September 10, 2025
GluN2A-NMDA receptor inhibition disinhibits the prefrontal cortex, reduces forced swim immobility, and impairs sensorimotor gatingYuan-Ping Dong, Yun Wu, Yi-Lu Zhao, et al.
Cancer Letters|February 10, 2024
NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14Zi-Yi Yang, Cheng Zhao, Shi-Lei Liu, et al.
The Science of the Total Environment|May 5, 2022
Fine and ultrafine airborne PM influence inflammation response of young adults and toxicological responses in vitroMo Yang, Pasi Jalava, Henri Hakkarainen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2003
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]Masahiro Fukuoka, Seiji Yano, Giuseppe Giaccone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2023
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung CancerMasahiro Fukuoka, Seiji Yano, Giuseppe Giaccone, et al.
Current Medical Science|May 27, 2024
Effect of Jianpi Shengxue Tablet on Iron Metabolism and Nutritional Status in Patients with Renal Anemia: A Prospective, Randomized, Open, Parallel Controlled and Multicenter Clinical StudyJuan Yang, Meng-Yuan Liang, Yu Li, et al.
BMC Cancer|September 30, 2024
Mutational signatures in 175 Chinese gastric cancer patientsFatao Liu, Nan Hu, Kewei Jiang, et al.
Clinical and Translational Medicine|May 1, 2021
4-phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR-αShu-Zhen Chen, Yan Ling, Le-Xing Yu, et al.
Pageof 106

Showing results (1011-1020 of 1,056) with videos related to

Sort By:
Pageof 106
Chinese Medical Journal|August 31, 2012
An uncontrolled open-label, multicenter study to monitor the antiviral activity and safety of inhaled zanamivir (as Rotadisk via Diskhaler device) among Chinese adolescents and adults with influenza-like illnessBin Cao, Da-Yan Wang, Xiao-Min Yu, et al.
Cell|April 21, 2010
TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formationXiping Cheng, Jie Jin, Lily Hu, et al.
Acta Pharmacologica Sinica|September 10, 2025
GluN2A-NMDA receptor inhibition disinhibits the prefrontal cortex, reduces forced swim immobility, and impairs sensorimotor gatingYuan-Ping Dong, Yun Wu, Yi-Lu Zhao, et al.
Cancer Letters|February 10, 2024
NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14Zi-Yi Yang, Cheng Zhao, Shi-Lei Liu, et al.
The Science of the Total Environment|May 5, 2022
Fine and ultrafine airborne PM influence inflammation response of young adults and toxicological responses in vitroMo Yang, Pasi Jalava, Henri Hakkarainen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2003
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]Masahiro Fukuoka, Seiji Yano, Giuseppe Giaccone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2023
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung CancerMasahiro Fukuoka, Seiji Yano, Giuseppe Giaccone, et al.
Current Medical Science|May 27, 2024
Effect of Jianpi Shengxue Tablet on Iron Metabolism and Nutritional Status in Patients with Renal Anemia: A Prospective, Randomized, Open, Parallel Controlled and Multicenter Clinical StudyJuan Yang, Meng-Yuan Liang, Yu Li, et al.
BMC Cancer|September 30, 2024
Mutational signatures in 175 Chinese gastric cancer patientsFatao Liu, Nan Hu, Kewei Jiang, et al.
Clinical and Translational Medicine|May 1, 2021
4-phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR-αShu-Zhen Chen, Yan Ling, Le-Xing Yu, et al.
Pageof 106